Terms: = Leukemia AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
114 results:
1. A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes.
Bao Y; Yang S; Zhao H; Wang Y; Li K; Liu X; Zhang W; Zhu X
BMC Pulm Med; 2024 Apr; 24(1):176. PubMed ID: 38609879
[TBL] [Abstract] [Full Text] [Related]
2. Unlocking the potential: A novel prognostic index signature for acute myeloid leukemia.
Zhang LQ; Liang YC; Wang JX; Zhang J; La T; Li QZ
Comput Biol Med; 2024 May; 173():108396. PubMed ID: 38574529
[TBL] [Abstract] [Full Text] [Related]
3. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
[TBL] [Abstract] [Full Text] [Related]
4. [MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid leukemia].
Gan DY; Wu J; Zhou M; Chen W; Jiang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):39-44. PubMed ID: 38387897
[TBL] [Abstract] [Full Text] [Related]
5. THE COURSE OF CHRONIC LYMPHOCYTIC leukemia AFTER SARS-COV-2 VIRUS INFECTION.
Dyagil IS; Abramenko IV; Martina ZV; Golyarnic NA; Brychenko VV; Movchan AV; Chumak AA; Bazyka DA
Probl Radiac Med Radiobiol; 2023 Dec; 28():267-276. PubMed ID: 38155128
[TBL] [Abstract] [Full Text] [Related]
6. Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid leukemia.
Dancik GM; Varisli L; Tolan V; Vlahopoulos S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761947
[TBL] [Abstract] [Full Text] [Related]
7. A 16-year bicentric retrospective analysis of ovarian tissue cryopreservation in pediatric units: indications, results, and outcome.
Grellet-Grün M; Delepine B; Le Van Quyen P; Avérous G; Durlach A; Greze C; Ladureau-Fritsch L; Lichtblau I; Canepa AS; Liné A; Paillard C; Pluchart C; Pirrello O; Rongieres C; Harika G; Becmeur F; Teletin M
Front Endocrinol (Lausanne); 2023; 14():1158405. PubMed ID: 37720539
[TBL] [Abstract] [Full Text] [Related]
8. SUMO specific peptidase 1 decreases after induction treatment, and its reduction predicts lower disease risk, better treatment response, longer survival of acute myeloid leukemia.
Liu J; Li Y; Zhang G
Scand J Clin Lab Invest; 2023 Sep; 83(5):283-289. PubMed ID: 37405376
[TBL] [Abstract] [Full Text] [Related]
9. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study.
Islam MR; Osman OI; Hassan WMI
J Biomol Struct Dyn; 2024; 42(1):82-100. PubMed ID: 36995071
[TBL] [Abstract] [Full Text] [Related]
10. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland.
Kero AE; Taskinen M; Volin L; Löyttyniemi E; Itälä-Remes M; Lähteenmäki PM
Int J Cancer; 2023 Jun; 152(11):2292-2302. PubMed ID: 36760204
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
[No Abstract] [Full Text] [Related]
12. [The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].
Wang H; Zhao T; Hu LJ; Li ZR; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):550-556. PubMed ID: 36709131
[No Abstract] [Full Text] [Related]
13. Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome.
Hara R; Kitahara T; Numata H; Toyosaki M; Watanabe S; Kikkawa E; Ogawa Y; Kawada H; Ando K
Int J Hematol; 2023 May; 117(5):684-693. PubMed ID: 36574168
[TBL] [Abstract] [Full Text] [Related]
14. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
15. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Zimmermann H; Koenecke C; Dreyling MH; Pott C; Dührsen U; Hahn D; Meidenbauer N; Hauser IA; Rummel MJ; Wolf D; Heuser M; Schmidt C; Schlattmann P; Ritgen M; Siebert R; Oschlies I; Anagnostopoulos I; Trappe RU
Leukemia; 2022 Oct; 36(10):2468-2478. PubMed ID: 35974101
[TBL] [Abstract] [Full Text] [Related]
16. Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100/miR-217/ATP1B1 axis.
Cao J; Huang S; Li X
Exp Hematol; 2022; 112-113():60-69.e2. PubMed ID: 35901982
[TBL] [Abstract] [Full Text] [Related]
17. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature.
Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW
Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287
[TBL] [Abstract] [Full Text] [Related]
18. [Efficacy of Chimeric Antigen Receptor T Cell in the treatment of Refractory/Recurrent B Acute Lymphocytic leukemia in Children].
Yang F; Wang TY; DU WW; He HL; Xiao PF; Lu Y; Hu SY; Li BS; Lu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):718-725. PubMed ID: 35680795
[TBL] [Abstract] [Full Text] [Related]
19. Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
Jazowski SA; Wilson L; Dusetzina SB; Zafar SY; Zullig LL
JAMA Netw Open; 2022 Jun; 5(6):e2215720. PubMed ID: 35671056
[TBL] [Abstract] [Full Text] [Related]
20. [Пятилетнее исследование влияния кардиомониторинга на общую выживаемость больных хроническим лимфолейкозом, получающих таргетную терапию ибрутинибом].
Emelina EI; Gendlin GE; Nikitin IG
Kardiologiia; 2022 Apr; 62(4):20-29. PubMed ID: 35569160
[TBL] [Abstract] [Full Text] [Related]
[Next]
